en

PRODUCT DETAIL

Levodopa/Carbidopa/Entacapone Stada 200 mg/50 mg/200 mg

Code 1530B
MA number 27/0323/14-S
Product Form: tbl flm 200x200 mg/50 mg/200 mg (nád.HDPE)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 27 - ANTIPARKINSONICA
ATC:
N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS
N04B DOPAMINERGIC AGENTS
N04BA Dopa and dopa derivatives
N04BA03 LEVODOPA, DECARBOXYLASE INHIBITOR AND COMT INH.
Shelf life: 24
Container: HDPE tablet container
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 26.09.2014
SPC: SPC_Levodopa-Carbidopa-Entacapone Stada_10.2023.pdf  
PIL: PIL_Levodopa-Carbidopa-Entacapone Stada_10.2023.pdf  
Safety feature Yes
Data update: 23.04.2019
eu-flag.png sk-flag.png